Naunyn-Schmiedebergs Archives of Pharmacology 2004-08-01

Cloricromene in endotoxemia: role of NF-kappaB.

A Ianaro, P Maffia, G Grassia, P Di Meglio, R Sorrentino, R d'Emmanuele di Villa Bianca, M Di Rosa, A Ialenti

Index: Naunyn Schmiedebergs Arch. Pharmacol. 370(2) , 140-5, (2004)

Full Text: HTML

Abstract

In this study we investigated, for the first time in vivo, the effect of cloricromene, a cumarine derivative, on NF-kappaB activation in endotoxin-treated rats. Endotoxemia was induced in male rats by the intravenous injection of Salmonella typhosa lipopolysaccharide (LPS; 2 mg/kg/i.v.). In vivo treatment with cloricromene (2 mg/kg/i.v.) 30 min before lipopolysaccharide administration reversed the LPS-induced loss in tone of the aortic rings, improved their reactivity to phenylephrine, decreased both nitric oxide (NO) and TNF-alpha serum levels by inhibiting LPS-induced inducible NO synthase and TNF-alpha mRNA expression, and interestingly inhibited LPS-induced NF-kappaB activation. Our data suggest that cloricromene protects rats from LPS by blocking LPS-induced NF-kappaB activation, leading to inhibition of NO and TNF-alpha overproduction and thereby reversing the LPS-induced vascular hyporeactivity.